JPS6040437B2 - Oxazolinoazetidine derivatives - Google Patents

Oxazolinoazetidine derivatives

Info

Publication number
JPS6040437B2
JPS6040437B2 JP52001760A JP176077A JPS6040437B2 JP S6040437 B2 JPS6040437 B2 JP S6040437B2 JP 52001760 A JP52001760 A JP 52001760A JP 176077 A JP176077 A JP 176077A JP S6040437 B2 JPS6040437 B2 JP S6040437B2
Authority
JP
Japan
Prior art keywords
compound
days
reaction
group
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52001760A
Other languages
Japanese (ja)
Other versions
JPS5387388A (en
Inventor
好男 浜島
美鶴 吉岡
庄一郎 上尾
照二 辻
郁男 橘川
亘 永田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to JP52001760A priority Critical patent/JPS6040437B2/en
Priority to GR54966A priority patent/GR69788B/el
Priority to CA293,599A priority patent/CA1090806A/en
Priority to ZA00777646A priority patent/ZA777646B/en
Priority to AR270584A priority patent/AR223140A1/en
Priority to DK588477A priority patent/DK161330C/en
Priority to GB248/78A priority patent/GB1554821A/en
Priority to PT67498A priority patent/PT67498B/en
Priority to NZ186153A priority patent/NZ186153A/en
Priority to AT9578A priority patent/AT353967B/en
Priority to AU32200/78A priority patent/AU511062B2/en
Priority to YU30/78A priority patent/YU41024B/en
Priority to IE35/78A priority patent/IE46134B1/en
Priority to ES465828A priority patent/ES465828A1/en
Priority to NLAANVRAGE7800262,A priority patent/NL185668C/en
Priority to SU782562902A priority patent/SU791243A3/en
Priority to IL53770A priority patent/IL53770A/en
Priority to FI780059A priority patent/FI67551C/en
Priority to NO780071A priority patent/NO162561C/en
Priority to DD78203150A priority patent/DD135617A5/en
Priority to BG038345A priority patent/BG33290A3/en
Priority to SE7800192A priority patent/SE447114B/en
Priority to FR7800467A priority patent/FR2376861A1/en
Priority to MX786761U priority patent/MX4998E/en
Priority to PL1978203903A priority patent/PL115874B1/en
Priority to CH20178A priority patent/CH638528A5/en
Priority to BE184233A priority patent/BE862793A/en
Priority to DE2800860A priority patent/DE2800860C2/en
Priority to PH20690A priority patent/PH16072A/en
Priority to HU78SI1611A priority patent/HU173779B/en
Priority to US05/868,422 priority patent/US4220766A/en
Publication of JPS5387388A publication Critical patent/JPS5387388A/en
Priority to SU782665605A priority patent/SU791244A3/en
Priority to ES473977A priority patent/ES473977A1/en
Priority to US06/112,144 priority patent/US4271295A/en
Priority to US06/112,145 priority patent/US4271296A/en
Priority to FI820013A priority patent/FI68838C/en
Priority to FI831571A priority patent/FI70712C/en
Publication of JPS6040437B2 publication Critical patent/JPS6040437B2/en
Priority to NO890056A priority patent/NO167289C/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

【発明の詳細な説明】 この発明は抗生物質の合成中間体として有用なオキサゾ
リノアゼチジン化合物(1)とその製造方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an oxazolinoazetidine compound (1) useful as an intermediate for the synthesis of antibiotics and a method for producing the same.

式(1)で表わされる化合物(1)は、式(0)で表わ
されるペニシリン・1−オキシド化合物(0)を開閉環
反応に付して製造する。
Compound (1) represented by formula (1) is produced by subjecting penicillin 1-oxide compound (0) represented by formula (0) to a ring-opening and closing reaction.

(式中、Rはアラルキル、フエノキシメチルまたはアリ
ール基;Bは低級アルコキシ、アラルコキシまたはニト
ロアラルコキシ基;Xは水素、ハロゲンまたは低級アル
カノイルオキシ基;をそれぞれ示す)化合物(1)は化
合物(0)を開閉環反応に付せば製造できる。
(In the formula, R is an aralkyl, phenoxymethyl or aryl group; B is a lower alkoxy, aralkoxy or nitroaralkoxy group; X is hydrogen, halogen or a lower alkanoyloxy group; respectively) Compound (1) is a compound (0) It can be produced by subjecting it to a ring-opening and closing reaction.

化合物(ロ)はJ.Chem.Soc.Perkin
l l973932に準じて製造できる。この開閉環反
応は実施例に記した通りに加熱のみでも起る(ベンゼン
十N・N−ジメチルアセトアミド(3:2)鷹液中還流
した例)ので、特に試薬が必須ではない。この反応は化
合物(ロ)からスルフェン酸を生成させ、これに脱硫反
応を施こすことにより実施されるので、前段は所謂、ペ
ニシリンスルホキシドからデアセトキシセフアロスポラ
ン酸を製造する条件が適用でき、後段は脱硫剤を添加す
ることにより促進できる。
Compound (b) is described in J. Chem. Soc. Perkin
It can be manufactured according to l973932. This ring-opening/closing reaction can occur by heating alone as described in the examples (example in which benzene and N.N-dimethylacetamide (3:2) were refluxed in hawk liquor), so no particular reagent is essential. This reaction is carried out by producing sulfenic acid from compound (2) and subjecting it to a desulfurization reaction, so the conditions for producing deacetoxycephalosporanic acid from penicillin sulfoxide can be applied in the first stage, and in the second stage can be promoted by adding a desulfurization agent.

ここに、脱硫剤としては三価りん化合物(トリアリール
ホスホラン、トリアルキルホスホラン、トリアルコキシ
ホスホランなど)、硫黄化合物(スルフェン酸、スルフ
イン酸、亜硫酸塩など)、ハロゲン化合物(分子状ハロ
ゲン、N−ハロアミド、N−ハロイミドなど)、酸(有
機酸、無機酸)、酸無水物、その他の硫黄原子に親和性
のある化合物が用いられる。反応中にオキシドに由釆す
る水が発生するが、分子節を反応液に添加するか、還流
液を乾燥することにより、除去できる。しかし、この反
応には脱水条件は必須ではない。この反応は溶媒中実施
するのが好ましい。
Here, as desulfurizing agents, trivalent phosphorus compounds (triarylphosphorane, trialkylphosphorane, trialkoxyphosphorane, etc.), sulfur compounds (sulfenic acid, sulfinic acid, sulfites, etc.), halogen compounds (molecular halogen, N-haloamide, N-haloimide, etc.), acids (organic acids, inorganic acids), acid anhydrides, and other compounds having an affinity for sulfur atoms are used. During the reaction, water that dissolves in the oxide is generated, but it can be removed by adding a molecule to the reaction solution or by drying the reflux solution. However, dehydration conditions are not essential for this reaction. Preferably, this reaction is carried out in a solvent.

溶媒は炭化水素(ベンゼン、トルェン、ヘキサンなど)
、ハロ炭化水素(塩化メチレン、ジクロロエタン、トリ
クロロエタン、クロロベンゼンなど)、エーテル(ジオ
キサン、テトラヒドロフランなど)、アミド(N・N−
ジメチルホルムアミド、N・N−ジメチルアセトアミド
、ヘキサメチルホスホロトリアミドなど)、ェステル(
酢酸エチル、酢酸アミルなど)、アルコール(エタノー
ル、ブタノール、t−プタノールなど)、その他の種々
の不活性溶媒が著しい収率低下ないこ用いられる。
The solvent is a hydrocarbon (benzene, toluene, hexane, etc.)
, halohydrocarbons (methylene chloride, dichloroethane, trichloroethane, chlorobenzene, etc.), ethers (dioxane, tetrahydrofuran, etc.), amides (N/N-
dimethylformamide, N/N-dimethylacetamide, hexamethylphosphorotriamide, etc.), esters (
Ethyl acetate, amyl acetate, etc.), alcohols (ethanol, butanol, t-butanol, etc.), and various other inert solvents can be used without significantly reducing the yield.

反応温度は70℃〜130qoが好ましい。The reaction temperature is preferably 70°C to 130qo.

70℃以下でも反応は進行するが、反応がおそく、13
0午C以上でも反応は進行するが、分解産物が増加する
Although the reaction proceeds below 70°C, the reaction is slow and 13
Although the reaction proceeds at temperatures above 0 pm, the amount of decomposition products increases.

反応は通常、高温では数分で、低温では数時間で終了す
る。このようにして製造した化合物は分子節を入れたと
きはこれを炉去し、水洗、乾燥後、濃縮し、要すればシ
リカゲルクロマトなどで精製するなど、常法により単欧
、精製すれば容易に単離することができる。
The reaction usually completes within a few minutes at high temperatures and several hours at low temperatures. The compound produced in this way can be easily purified by conventional methods such as removing it in an oven, washing it with water, drying it, concentrating it, and purifying it with silica gel chromatography if necessary. can be isolated to

このようにして製造した化合物(1)は抗生物質の合成
中間体として利用することができる。
Compound (1) thus produced can be used as a synthetic intermediate for antibiotics.

たとえば、化合物(1)を塩基と処理すれば式(血)で
表わされる化合物(m)を製造できる。(式中、COB
、R、Xは前記と同意義)この反応も前記反応と同様な
不活性溶媒中、有機塩基(ァルキルアミン、ァラルキル
アミン、など)または無機塩基(アルカリ金属の水酸化
物、炭酸塩など)を、例えば0℃〜7000で1分ない
し5時間作用させれば容易に実施できる。
For example, by treating compound (1) with a base, compound (m) represented by the formula (blood) can be produced. (In the formula, COB
(R, This can be easily carried out by reacting at 0° C. to 7,000° C. for 1 minute to 5 hours.

Rがアリールである化合物(m)はオキサゾリン環の開
裂反応を促進するので重要である。
Compounds (m) in which R is aryl are important because they promote the cleavage reaction of the oxazoline ring.

化合物(m)はプロパルギル・アルコールを作用させた
のち水和し、アゼチジノンの1位の側鎖をオゾン開裂後
還元、ハロゲン置換したのち、トリフェニルホスフイン
を作用させてウイテイヒ試薬を作り、閉環することによ
り、1ーオキサデチァセファロスポリンを製造すること
ができる。本発明方法によれば特顔昭51−13580
び号‘こ記載の方法よりも高収率で、副反応少なく目的
とする1ーオキサデチアセフアロスポリンを製造するこ
とができる。化合物(1)はェキソメチレン基を四酸化
オスミウムでジオールに変えたのち、三ふつ化ほう素を
作用させて閉環し、生成物を脱水することによって、公
知方法よりも容易に1−オキサデチアセフアロスポリン
を製造することができる。
Compound (m) is hydrated after being treated with propargyl alcohol, and the side chain at position 1 of azetidinone is cleaved with ozone, reduced, and replaced with halogen, and then treated with triphenylphosphine to produce the Wittig reagent and ring-closed. In this way, 1-oxadethiacephalosporin can be produced. According to the method of the present invention, special face Sho 51-13580
The desired 1-oxadethiacephalosporin can be produced with a higher yield and fewer side reactions than the method described in No. 1. Compound (1) can be easily converted to 1-oxadethiacephyl by converting the exomethylene group into a diol with osmium tetroxide, then ring-closing with boron trifluoride, and dehydrating the product. Allosporin can be produced.

前記の通り、この発明は有用な中間体とその能率の高い
製法を提供するものである。
As mentioned above, the present invention provides a useful intermediate and a highly efficient method for producing the same.

以下に実施例を記載して本発明の実例と製法を説明する
Examples and manufacturing methods of the present invention will be described below with reference to Examples.

例1 ペニシリン・1ーオキシド(ロ)からオキサゾ1」ノア
ゼチジン化合物(1)の製造第1表は標記開閉環反応の
反応条件を例示する。
Example 1 Preparation of oxazo 1'' noazetidine compound (1) from penicillin 1-oxide (b) Table 1 illustrates the reaction conditions for the title ring opening and closing reaction.

第0表は生成物の物理定数を示す。Table 0 shows the physical constants of the products.

操作の詳細を示すため、第1表No.8の反応と後処理
の操作を以下に記載する。
To show the details of the operation, Table 1 No. The reaction and post-treatment operations in step 8 are described below.

(No.10) 6Qーベンズアミドベニシラン酸ジフェニルメチルエス
テル・1ーオキシド38.51夕とトリフエニルホスフ
イン22.11夕とをトルエン308仇‘と1・2−ジ
クロロヱタン308の‘との混液にとかし、分子節をつ
めたデイーン・スターク型脱水器により留液を脱水しな
がら3.虫時間還流する。
(No. 10) Dissolve 38.51 parts of 6Q-benzamidobenicillanic acid diphenylmethyl ester 1-oxide and 22.11 parts of triphenylphosphine into a mixed solution of 308 parts of toluene and 308 parts of 1,2-dichloroethane. 3. While dehydrating the distillate using a Dean-Stark type dehydrator packed with molecular nodes. Insect time reflux.

冷後、反応液を150の‘まで濃縮したのち、10%含
水シリカゲル500タ上クロマトグラフして精製し、ベ
ンゼン+酢酸エチル(19:1)と(4:1)で流出す
る部分をエーテルから結晶化させればQ一(3−フエニ
ルー7−オキソー4ーオキサー2・6ージアザビシクロ
〔3・2・0〕へプトー2ーエンー6ーィル)−Qーィ
ソプロベニル酢酸ジフェニルメチルェステル28.15
夕を得る。収率:81.2%。mPI16.5〜118
00。例2 化合物(1)から二重結合の異性体(m)の製造【1)
Q−(3−フエニルー7ーオキソー4ーオキサー2・
6−ジアザピシクロ〔3・2・0〕へプトー2−エン−
6ーイル)一は−イソプロベニル酢酸pーニトロベンジ
ル281の9を塩化メチレン2の‘にとかし、これにト
リエチルアミン48山夕を加えて室温で15分間放置す
る。
After cooling, the reaction solution was concentrated to 150% and purified by chromatography on 10% hydrated silica gel (500 ml). When crystallized, Q-(3-phenyl-7-oxo-4-oxer-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)-Q-isoprobenylacetic acid diphenylmethyl ester 28.15
Get the evening. Yield: 81.2%. mPI16.5-118
00. Example 2 Production of double bond isomer (m) from compound (1) [1]
Q-(3-phenyl7-oxo4-oxer2.
6-diazapicyclo[3.2.0]heptoe-2-ene-
Dissolve 281-9 of p-nitrobenzyl isoprobenyl acetate in 2-2 of methylene chloride, add 48 of triethylamine, and let stand at room temperature for 15 minutes.

反応液を減圧濃縮すればQ−(3ーフェニルー7ーオキ
ソー4ーオキサ−2・6−ジアザビシクロ〔3・2・0
〕へプトー2ーエンー6ーイル)−q−ィソプロピリデ
ン酢酸p−ニトロベンジル278の9を得る。
By concentrating the reaction solution under reduced pressure, Q-(3-phenyl-7-oxo-4-oxa-2,6-diazabicyclo[3,2,0
] Hept-2-en-6-yl)-q-isopropylidene p-nitrobenzyl acetate 278-9 is obtained.

収率:定量的。泡状物。NMR:6CDC131.96
3日、2.3$9日、5.0$IH、5.1$IH、5
.4桝(3HZ)IH、6.17d(3HZ)IH、7
.3−7.6十7.9−8.4m。‘21前記【1’と
同様にしてQ−(3ーベンジル−7ーオキソ−4ーオキ
サー2・6−ジアザビシクロ〔3・2・0〕へプトー2
ーエン−6ーイル)−Qーィソプロベニル酢酸ジフェニ
ルメチル75Mを塩化メチレン5の‘中トリェチルァミ
ン0.03羽と室温で1時間かきまぜれば、Q−(3ー
ベンジル−7ーオキソ−4ーオキサー2・6ージアザビ
シクロ〔3・2・0〕へプト−2ーェンー6ーィル)−
Q−ィソプロピリデン酢酸ジフヱニルメチルを得る。m
pl04.5〜106qo。収率:95%。参考例 1 原料の製造(その1) ×=CQCOO− XニCI− ‘ィ)化合物{1’3.63夕と2ーメルカプトベンゾ
チアゾール1.14夕とをトルェン中45分還流後濃縮
する。
Yield: Quantitative. Foamy matter. NMR:6CDC131.96
3 days, 2.3$9 days, 5.0$IH, 5.1$IH, 5
.. 4 squares (3HZ) IH, 6.17d (3HZ) IH, 7
.. 3-7.6 7.9-8.4m. '21 In the same manner as in [1' above]
-en-6-yl)-Q-isoprobenylacetate 75M diphenylmethyl acetate is stirred with 0.03 triethylamine in methylene chloride 5' at room temperature for 1 hour, Q-(3-benzyl-7-oxo-4-oxer 2,6-diazabicyclo[3・2.0〕Hept-2-en-6-il)-
Q-isopropylidene diphenylmethyl acetate is obtained. m
pl04.5-106qo. Yield: 95%. Reference Example 1 Production of raw materials (Part 1) ×=CQCOO-

残留物を少量の塩化メチレンにとかし、石油エーテルを
加えて晶出させれば化合物■2.90夕を得る。mp8
3〜8600。IR:〃昇段CI33430、3005
、1785、1745、1700肌一10NMR: 6
C0o13 1.9かm3日 、 4.47s2日
、5.01sIH、4.9‐5.3h犯、5,17d(
2日2)IH、6.9$IH、6.8−8.1mlSH
The residue was dissolved in a small amount of methylene chloride, and petroleum ether was added to crystallize it to obtain compound (2). mp8
3-8600. IR:〃Ascension CI33430, 3005
, 1785, 1745, 1700 skin 10NMR: 6
C0o13 1.9m3 days, 4.47s2 days
, 5.01s IH, 4.9-5.3h crime, 5,17d (
2 days 2) IH, 6.9$ IH, 6.8-8.1mlSH
.

(口) −化合物■1.36夕、酢酸銀 400のp、および酢酸1私を酢酸エチル21舷【中室
温で3時間かきまぜる。
(mouth) - Compound ■ 1.36 minutes, 400 parts of silver acetate and 1 part of acetic acid were stirred at room temperature for 3 hours in 21 parts of ethyl acetate.

不落物を沢去した反応液を濃縮し、得られる残留物を1
0%合水シリカゲル15タ上クロマトグラフすれば、ベ
ンゼン十酢酸エチル(95:5)混液で溶出する分画よ
り化合物糊460の9を得る。IR:レ樹SI3341
5・3005・1785・1745・1696・160
0Cの一10NMR:6CDC131.21s班、2.
1瓜組、3,84d(11.5HZ)IH、4.2母(
11.5日2)IH、4.5$2日、4.8$IH、5
.2紅d(9;2HZ)IH、5.3斑(2日2)IH
、6.9$IH、6.8−7.8ml印。
The reaction solution from which the impurities have been removed is concentrated, and the resulting residue is 1
By chromatography on 0% diluted silica gel 15 ta, compound paste 460-9 is obtained from the fraction eluted with a mixture of benzene and decaacetate (95:5). IR: Reju SI3341
5.3005.1785.1745.1696.160
0C 110NMR: 6CDC131.21s group, 2.
1 melon group, 3.84d (11.5HZ) IH, 4.2 mother (
11.5 days 2) IH, 4.5 dollars 2 days, 4.8 dollars IH, 5
.. 2 red d (9; 2HZ) IH, 5.3 spots (2 days 2) IH
, 6.9$ IH, 6.8-7.8ml mark.

し一−化合物(3}785の9を20%合 水ピリジン1.4の‘にとかし、ヨードベンゼンジクロ
リド760のoのピリジン溶液1.4机を加えて室温で
1時間半かきまぜる。
Compound (3) Dissolve 9 of 785 in 1.4 of a 20% solution of pyridine, add 1.4 of a solution of 760 of iodobenzene dichloride in pyridine, and stir at room temperature for 1.5 hours.

反応液に酢酸エチル50の‘を加えて不溶物を炉去し、
炉液を減圧濃縮する。残留物をシリカゲルカラムクロマ
トにより精製すれば、ベンゼン+酢酸エチル(1:1)
混液で溶出する分画より化合物州09のQを得る。IR
:レ薄身133420・3010・1795・1750
・1700・1600弧‐10NMR : 6 CDC
13 1.0$9日 、 2.1$3日 、4,3枇r
sが、4,56が、5,Old(2,3HZ)IH、5
.62dd(2.3;9HZ)IH、6.9$IH、6
.9−7.7ml班、7.8虹(9HZ)IH。
Add 50% of ethyl acetate to the reaction solution and remove the insoluble matter in an oven.
Concentrate the furnace liquid under reduced pressure. If the residue is purified by silica gel column chromatography, benzene + ethyl acetate (1:1)
Compound 09 Q is obtained from the fraction eluted with the mixed solution. IR
: Le thin 133420/3010/1795/1750
・1700・1600 arc-10NMR: 6 CDC
13 1.0 $9 days, 2.1 $3 days, 4,3 r
s is 4, 56 is 5, Old (2,3HZ) IH, 5
.. 62dd (2.3; 9HZ) IH, 6.9$ IH, 6
.. 9-7.7ml group, 7.8 Rainbow (9HZ) IH.

Q (×=CI)−化合物■6.66夕と塩化第二銅3
.33夕を塩化メチレン100の‘にとかし、室温で3
時間かきまぜる。
Q (×=CI)-Compound ■6.66 and cupric chloride 3
.. Dissolve 33% of dichloromethane in 100% methylene chloride and dissolve 33% of it at room temperature.
Stir the time.

不溶物を炉去して得られる炉液を減圧濃縮し10%合水
シリカゲル上クロマトグラフして精製すれば化合物湖(
×=CI)2.72夕を得る。収率:50%。IR:レ
局繋o133415、1790、1750、1700、
1605伽一10NMR:6CoCI31.27s9日
、3.47s2日、4.4$2日、5.1$IH、5.
12dd(8HZ;1.5HZ)IH、5.2斑(1.
5HZ)IH、6.8$IH、6.5‐7.5ml弧、
7.54d(8日2)IH。
The insoluble matter is removed in the furnace, the resulting furnace liquid is concentrated under reduced pressure, and purified by chromatography on 10% fused silica gel to form a compound lake (
×=CI) 2.72 evenings are obtained. Yield: 50%. IR: station connection o133415, 1790, 1750, 1700,
1605 Kayi 10NMR: 6CoCI31.27s 9 days, 3.47s 2 days, 4.4$2 days, 5.1$IH, 5.
12dd (8HZ; 1.5HZ) IH, 5.2 spots (1.
5HZ) IH, 6.8$IH, 6.5-7.5ml arc,
7.54d (8th day 2) IH.

的 (X=CI)−化合物(3’(X=CI)2.45
夕を20%含水ピリジン4.5の‘にとかし、ヨードベ
ンゼンジクロリド2.45夕のピリジン溶液4.5の‘
を氷冷下に加え、室温にもとして1時間かきまぜる。
(X=CI)-Compound (3'(X=CI)2.45
Dissolve the solution in 4.5 parts of 20% aqueous pyridine and add 2.45 parts of iodobenzene dichloride to 4.5 parts of the pyridine solution.
Add to the mixture under ice-cooling, bring to room temperature, and stir for 1 hour.

反応液を酢酸エチル200地にうすめ、不溶物を炉去す
る。残留物を含水シリカゲル45タ上クロマトグラフす
れば、ベンゼン十酢酸エチル(4:1)で港出する分画
より化合物‘4ー(X=CI)1.23夕を得る。収率
:49%。IR:〃三愛o133415、1795、1
755、1700、1600肌一10NMR: 6 C
DC13 1.07s3日 、 3.70brs2日
、4.47s2日、4.90brsIH、5.0瓜IH
、5.4&rd(8HZ)IH、6.97sIH、6.
8−7.5ml弧、8.00brd(8HZ)IH。
The reaction solution was diluted with 200 ml of ethyl acetate, and insoluble matter was removed in an oven. The residue was chromatographed on 45 ml of hydrous silica gel, and 1.23 g of compound '4-(X=CI) was obtained from fractionation with benzene-ethyl decacetate (4:1). Yield: 49%. IR:〃Sanai o133415, 1795, 1
755, 1700, 1600 skin 10NMR: 6C
DC13 1.07s 3 days, 3.70brs 2 days
, 4.47s 2 days, 4.90brsIH, 5.0melon IH
, 5.4&rd (8HZ) IH, 6.97sIH, 6.
8-7.5ml arc, 8.00brd (8HZ) IH.

参考例 2 原料の製造(その2) ‘ィ’参考例1【ィ}と同様にして化合物‘5}1.0
2夕と2ーメルカプトベンゾチアゾール0.35夕をト
ルエン30必中還流すれば化合物【6}を得る。
Reference Example 2 Production of raw materials (Part 2) Compound '5} 1.0 in the same manner as Reference Example 1 [A]
Compound [6} is obtained by refluxing 0.35 mmol of 2-mercaptobenzothiazole and 0.35 mm of 2-mercaptobenzothiazole for 30 hours in toluene.

NMR:6C。CI31.97s3日、4.47s2日
、4.80−5.25h班 、5,4紅( I HZ
)、 6.80‐7.92h12日、8.1の(4HZ
)が。to) 前記【ィーの反応液に酢酸5の‘と酢酸
銀0.7夕とを加え、参考例2‘ローと同様に処理すれ
ば化合物(710.54夕と7ーフエノキシアセトアミ
ド−3ーメチルー3−アセトキシセフアム−4−力ルボ
ン酸pーニトロベンジル0.18夕の混合物を得る。N
MR:6C0CI31.3$、1.8$、1.9$、3
.4紅(2HZ)、3.67十4.2乳(6日2)、4
.5$、4.87s、5.3瓜、5.07一5.4仇h
、6.83一7.73h、8.3の(4日2)。
NMR: 6C. CI31.97s 3 days, 4.47s 2 days, 4.80-5.25h group, 5,4 red (I HZ
), 6.80-7.92h12 days, 8.1 (4HZ
)but. To) Add 5 parts of acetic acid and 0.7 parts of silver acetate to the reaction solution of [A] and treat it in the same manner as in Reference Example 2' to form the compound (710.54 parts and 7-phenoxyacetamide). A mixture of 0.18 g of p-nitrobenzyl 3-methyl-3-acetoxycepham-4-carboxylate is obtained.
MR:6C0CI31.3$, 1.8$, 1.9$, 3
.. 4 red (2HZ), 3.67 14.2 milk (6 days 2), 4
.. 5$, 4.87s, 5.3melon, 5.07-5.4h
, 6.83-7.73h, 8.3 (4 days 2).

し一 参考例1Hと同様にして化合物‘7)0.45夕
をピリジン2叫と水0.4叫との涙液中ヨードベンゼン
ジクロリド520の9のピリジン溶液1.5の‘と室温
で3時間かきまぜれば化合物棚0.39夕を得る。
In the same manner as in Reference Example 1H, 0.45 g of compound '7) was mixed with 1.5 g of a solution of 520 g of iodobenzene dichloride in pyridine of 2 g of pyridine and 0.4 g of water at room temperature. If you stir for a while, you will get a compound shelf of 0.39 minutes.

泡状物。IR:リS繋131800、17551700
肌‐1。
Foamy matter. IR: ReS connection 131800, 17551700
Skin-1.

NMR : 6 C0CI3 1.3$乳日 、 2.
1瓜3日 、4.10brsが、4.57sが、4.8
7sIH、5.0母(IHZ)IH、5.3$が、5.
5紅d(1:4日2)IH、6.83‐7.42h班、
7.62十8.27q(4HZ)4日、7.9$(4H
Z)IH。二 Q ふ 船 聡 S べ 船 鶏 丈 11 白 ・ 短 ト 蛙 * ll n ‘ 入 L 造 ^ 鼓 Y ーー ミ; 生 。
NMR: 6 C0CI3 1.3$ milk day, 2.
1 melon 3 days, 4.10brs, 4.57s, 4.8
7sIH, 5.0 Mother (IHZ) IH, 5.3$, 5.
5 Beni d (1:4 day 2) IH, 6.83-7.42h group,
7.62 x 8.27q (4HZ) 4th, 7.9$ (4H
Z) IH. 2Q Fufune Satoshi S Befunekoi length 11 White short frog * ll n ' entered L construction ^ Drum Y - Mi; Raw.

【ミ雪.;章 斗)ト ;嶺安; ;室蓮≦ …言蓮喜 〜 の GI 」 ヒ旨こ; 章電車… 小言 oに暮あ qb 答 S S 船 隙 【( S 〜 略 口 雛 蟻 雌 詞 量 S S べ 略 日 斑 麓 量− S[Miyuki. ;chapter Do) ;Reiyasu; ;Muroren≦ …Konrenki ~'s G.I.' Hi Umiko; Chapter train… Nagging Live in o qb Answer S S ship Gap [( S ~ omitted mouth chick ant female lyrics amount S S Be omitted Day spots foot of the mountain Amount- S

Claims (1)

【特許請求の範囲】 1 次式で表わされる化合物: ▲数式、化学式、表等があります▼ (式中、 Rはアラルキル、フエノキシメチルまたはアリール基;
Bは低級アルコキシ、アラルコキシまたはニトロアラル
コキシ基;Xは水素、ハロゲンまたは低級アルカノイル
オキシ基;をそれぞれ示す)
[Claims] A compound represented by a primary formula: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, R is an aralkyl, phenoxymethyl, or aryl group;
B represents a lower alkoxy, aralkoxy or nitroaralkoxy group; X represents hydrogen, halogen or a lower alkanoyloxy group, respectively)
JP52001760A 1977-01-10 1977-01-10 Oxazolinoazetidine derivatives Expired JPS6040437B2 (en)

Priority Applications (38)

Application Number Priority Date Filing Date Title
JP52001760A JPS6040437B2 (en) 1977-01-10 1977-01-10 Oxazolinoazetidine derivatives
GR54966A GR69788B (en) 1977-01-10 1977-12-12
CA293,599A CA1090806A (en) 1977-01-10 1977-12-21 Oxazolines
ZA00777646A ZA777646B (en) 1977-01-10 1977-12-22 Oxazolines
AR270584A AR223140A1 (en) 1977-01-10 1977-12-29 PROCESS FOR THE PREPARATION OF ACID DERIVATIVES 2- (7-OXO-4-OXA-2,6-DIAZABICICLO (3.2.0) HEPT-2-EN-6-IL) -3-BUTENOLCO AND PROCEDURE FOR OBTAINING DERIVATIVES OF 2 - (7-OXO-4-OXA-2,6-DIAZABICICLO (3.2.0) HEPT-2-EN 6-IL) -2-BUTENOIC FROM THE ACIDES MENTIONED IN THE FIRST TERM
DK588477A DK161330C (en) 1977-01-10 1977-12-30 OXAZOLINOAZETIDE INGREDIENTS USED AS INTERMEDIATES IN THE PREPARATION OF 1-OXADETHIACEPHALOSPORINES AND PROCEDURES FOR THE PREPARATION OF THE OXAZOLINOAZETIDE INGREDIENTS
GB248/78A GB1554821A (en) 1977-01-10 1978-01-04 Oxazolines
PT67498A PT67498B (en) 1977-01-10 1978-01-05 A process for preparing of oxazolinoazetidine compounds
NZ186153A NZ186153A (en) 1977-01-10 1978-01-05 Oxazolinoazetidine compounds preparation form epipencillini-oxide
AT9578A AT353967B (en) 1977-01-10 1978-01-05 METHOD FOR PRODUCING NEW OXAZOLINE DERIVATIVES
AU32200/78A AU511062B2 (en) 1977-01-10 1978-01-05 Oxazolinoazetoine compounds
YU30/78A YU41024B (en) 1977-01-10 1978-01-06 Process for obtaining oxazolino-azetidine derivatives
IE35/78A IE46134B1 (en) 1977-01-10 1978-01-06 Oxazolines
ES465828A ES465828A1 (en) 1977-01-10 1978-01-07 Oxazolinoazetidine derivative
DD78203150A DD135617A5 (en) 1977-01-10 1978-01-09 PROCESS FOR THE PREPARATION OF OXAZOLINE DERIVATIVES
SU782562902A SU791243A3 (en) 1977-01-10 1978-01-09 Method of preparing oxazolinoazetidine compounds
IL53770A IL53770A (en) 1977-01-10 1978-01-09 Process for preparing oxazolino-azetidine compounds,some new compounds of this type and method of inhibiting growth of bacteria using them
FI780059A FI67551C (en) 1977-01-10 1978-01-09 PROCEDURE FOR FRAMSTATION OF ALPHA- (2R) -2 - ((1R 5S) -3-SUBSTITUTES 7-OXO-4-OXA-2,6-DIAZABICYCLO (3.2.0) HEPT-2-EN-6-YL) - 3-METHYL- AND HALOGEN-SUBSTITUTES METHYL-3-BUTENSYRAESTRAR FOR ANALYZING BUTTER PRODUCTS WITH FRAMSTAELLNING AV 7 ALA-METHOXY-1-OXA-DETIACEPHALOSPORINER
NO780071A NO162561C (en) 1977-01-10 1978-01-09 PROCEDURE FOR THE PREPARATION OF OKSAZOLINE COMPOUNDS SUITABLE FOR THE PREPARATION OF ANTIBACTERIAL EFFECTIVE 1-OKSA DETIACEPHALOSPORINES.
NLAANVRAGE7800262,A NL185668C (en) 1977-01-10 1978-01-09 PROCESS FOR PREPARING 7-OXO-4-OXA-2,6-DIAZABICYCLO (3,2,0) HEPT-2-ONE DERIVATIVES.
BG038345A BG33290A3 (en) 1977-01-10 1978-01-09 Method for obtaining of oxazolinazetidine
SE7800192A SE447114B (en) 1977-01-10 1978-01-09 OXAZOLINOAZETIDE COMPOUNDS FOR USE IN THE PREPARATION OF ANTIBACTERIAL 1-DETIA-1-OXACEPHALOSPORINES AND A PROCEDURE FOR PREPARING THEREOF
FR7800467A FR2376861A1 (en) 1977-01-10 1978-01-09 PROCESS FOR THE PREPARATION OF OXAZOLINES AND NEW PRODUCTS THUS OBTAINED, USEFUL FOR THE SYNTHESIS OF OXADETHIACEPHALOSPORINS
MX786761U MX4998E (en) 1977-01-10 1978-01-09 PROCEDURE FOR PREPARING OXAZOLINOAZETIDINE COMPOUNDS
PL1978203903A PL115874B1 (en) 1977-01-10 1978-01-09 Process for preparing novel derivatives of oxazolynazetidine
CH20178A CH638528A5 (en) 1977-01-10 1978-01-09 Oxazolines and processes for their preparation
US05/868,422 US4220766A (en) 1977-01-10 1978-01-10 Oxazolines
BE184233A BE862793A (en) 1977-01-10 1978-01-10 OXAZOLINOAZETIDINES
DE2800860A DE2800860C2 (en) 1977-01-10 1978-01-10 Alpha-oxazoline derivatives and process for their preparation
PH20690A PH16072A (en) 1977-01-10 1978-01-10 A 6-carboxybutenyl-7-oxo-1beta h, 5beta h-azetidinooxazoline,an intermediate for beta-lactam antibiotics
HU78SI1611A HU173779B (en) 1977-01-10 1978-01-10 Process for preparing oxazoline derivatives
SU782665605A SU791244A3 (en) 1977-01-10 1978-09-22 Method of preparing oxazolinoazetidine compounds
ES473977A ES473977A1 (en) 1977-01-10 1978-10-05 Oxazolinoazetidine derivative
US06/112,144 US4271295A (en) 1977-01-10 1980-01-14 Oxazolines
US06/112,145 US4271296A (en) 1977-01-10 1980-01-14 Oxazolines
FI820013A FI68838C (en) 1977-01-10 1982-01-05 SOM MELLANPRODUKT VID FRAMSTAELLNING AV 7ALFA-METOXI-1-OXADETIACEPHALOSPORINER ANVAENDBARA (1R, 5S) -7-OXO-4-OXA-2,6-DIAZABICYCLO (3.2.0) HEPT-2-EN-FOERENINGAR
FI831571A FI70712C (en) 1977-01-10 1983-05-06 SOM MELLANPRODUKT VID FRAMSTAELLNING AV 7BETA-ACYLAMINO-7ALFA-METOXI-1-OXADETIACEPHALOSPORINER ANVAENDBARA 2- / 7-OXO-3-SUBSTITUERAD-4-OXA-2,6-DIAZABICYCDBARA 2- / 7-O-OXXARA 2- / 7-O-O -OXA-2,6-DIAZABICYCLO / 3.2.0 / -HEPT-2-EN-6-YL / -HALOGENMETHYL-BUTENSYRLO / 3.2.0 / -HEPT-2-EN-6-YL / -HALOGENMETHYL-BUTENSYRADERATIVE ADERIVES
NO890056A NO167289C (en) 1977-01-10 1989-01-06 2,6-DIAZABICYCLO-HEPTENYL-HALOGENYL-BUTENIC ACID DERIVATIVES USEFUL AS THE BASIC PRODUCT FOR THE PREPARATION OF THERAPEUTIC ACTIVE CEFEM-4 CARBOXYLIC ACID DERIVATIVES.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52001760A JPS6040437B2 (en) 1977-01-10 1977-01-10 Oxazolinoazetidine derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP60011650A Division JPS6188A (en) 1985-01-24 1985-01-24 Oxazolinoazetidine derivative

Publications (2)

Publication Number Publication Date
JPS5387388A JPS5387388A (en) 1978-08-01
JPS6040437B2 true JPS6040437B2 (en) 1985-09-11

Family

ID=11510524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52001760A Expired JPS6040437B2 (en) 1977-01-10 1977-01-10 Oxazolinoazetidine derivatives

Country Status (15)

Country Link
JP (1) JPS6040437B2 (en)
AR (1) AR223140A1 (en)
AT (1) AT353967B (en)
BE (1) BE862793A (en)
BG (1) BG33290A3 (en)
DD (1) DD135617A5 (en)
ES (2) ES465828A1 (en)
GR (1) GR69788B (en)
HU (1) HU173779B (en)
MX (1) MX4998E (en)
PL (1) PL115874B1 (en)
PT (1) PT67498B (en)
SU (2) SU791243A3 (en)
YU (1) YU41024B (en)
ZA (1) ZA777646B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612395A (en) * 1979-07-10 1981-02-06 Shionogi & Co Ltd Oxazolinoazetidinone derivative

Also Published As

Publication number Publication date
MX4998E (en) 1983-02-02
AT353967B (en) 1979-12-10
BE862793A (en) 1978-05-02
PL203903A1 (en) 1979-04-23
ES473977A1 (en) 1980-02-16
DD135617A5 (en) 1979-05-16
YU3078A (en) 1983-02-28
SU791243A3 (en) 1980-12-23
PL115874B1 (en) 1981-05-30
PT67498A (en) 1978-02-01
JPS5387388A (en) 1978-08-01
SU791244A3 (en) 1980-12-23
YU41024B (en) 1986-10-31
AR223140A1 (en) 1981-07-31
GR69788B (en) 1982-07-07
PT67498B (en) 1979-06-08
ATA9578A (en) 1979-05-15
HU173779B (en) 1979-08-28
ZA777646B (en) 1978-10-25
BG33290A3 (en) 1983-01-14
ES465828A1 (en) 1979-01-01

Similar Documents

Publication Publication Date Title
JPH02300182A (en) Benzopyran derivative and production thereof
Padwa et al. (Nitroaryl) sulfinyl-substituted allenes. Novel and convenient propargyl alcohol synthons in 4+ 2 cycloaddition chemistry
US4237051A (en) Stereospecific production of 6- or 7-carbon-substituted-β-lactams
JPS6040437B2 (en) Oxazolinoazetidine derivatives
WO2004005276A1 (en) Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
JPS5924991B2 (en) Azetidine derivatives
JPS6058920B2 (en) Cephalosporin analogs
JPS5823875B2 (en) Process for producing α-isopropylidene-1-azetidine acetate and its acid
JPS6188A (en) Oxazolinoazetidine derivative
US4057540A (en) 4-Chloroazetidinone-1-(2',3'-dichloroisopropyl) acetates and process for preparing same
JPS61225183A (en) Manufacture of beta-carboline
JPS585917B2 (en) Process for producing silyl ester of azetidine↓-2↓-sulfenate
US3809700A (en) Certain 5,6-dioxopyrrolo(2,1-b)thiazoles
US3962276A (en) Azetidinone acetic acid intermediates for 5-epi-penicillins
US3867371A (en) Process for producing penicillin esters
US3875154A (en) Certain 5-thia-1-azabicyclo{8 4.2.0{9 octenes
US3799939A (en) Certain 6-carboxy-4-thia-1-azabicyclo(3.2.0)heptane compounds
US3962226A (en) 3-nitrooxycepham compounds and process for preparing desacetoxycephalosporins therefrom
JP3238512B2 (en) Method for producing sulfamides
JPS61243079A (en) 1-(alxoxycarbonylalkyl)-4-(2-furyl)-3-substituted-2-azetidinone and production thereof
JPS6339862A (en) Pyridylaminophenol derivative
US4159267A (en) Novel silyl ester azetidine-2-sulfenate intermediates and process for preparing desacetoxycephalosporins
JPS584788A (en) Penicillanic acid 1,1-dioxide derivative and its preparation
JPS5943477B2 (en) Method for producing cephalosporins
JPS62114966A (en) Production of n-pyridylhalothioformamide